Meeting

COT Meeting: 4th May 2021

Agenda and papers for the meeting of the Committee at 10.00am on Tuesday 4th May 2021

Last updated: 07 May 2021

Agenda and papers for the meeting of the Committee at 10.00am on Tuesday 4th May 2021

Meeting Agenda

1. Apologies for absence


2. Draft minutes of March meeting TOX/MIN/2021/02


3. Matters arising

• Update on JEGs and Regulated products


4. The potential effects that excess vitamin D intake may have during preconception, pregnancy and lactation- First draft statement TOX/2021/20


5. Addendum to the statement on the potential toxicological risks from electronic nicotine (and non-nicotine) delivery
systems (E(N)NDS – e-cigarettes): presence and pharmacokinetics of nicotine salts TOX/2021/21


6. A summary of data on the bioavailability of nicotine and other ingredients from the use of oral nicotine pouches and
assessment of risk to users. TOX/2021/22


7. Draft COT principles for assessing risks from less than lifetime exposure or variable exposure over a lifetime: Second draft statement TOX/2021/23


8. Discussion paper for the prioritisation of dietary components and xenobiotics for future papers on their effects on maternal
health – Part 2 TOX/2021/24


9. Alcohol and the maternal diet: The 2016 Chief Medical Officers report. TOX/2021/25


10. The potential effects of ginger and ginger supplements during pregnancy and lactation. TOX/2021/26


11. Update on the work of other advisory committees- for information TOX/2021/27


12. Any other business

Next meeting of the Committee at 10.00am on Tuesday 6th July 2021

Media discussed during the meeting

TOX/MIN/2021/02

Draft minutes of the meeting of the Committee at 10:00 on 2rd March via Microsoft Teams

TOX/2021/20

The potential effects that excess vitamin D intake may have during preconception, pregnancy and lactation -First draft statement

TOX/2021/21

Addendum to the statement on the potential toxicological risks from electronic nicotine (and non-nicotine) delivery
systems (E(N)NDS – e-cigarettes): presence and pharmacokinetics of nicotine salts

TOX/2021/22

A summary of data on the bioavailability of nicotine and other ingredients from the use of oral nicotine pouches and assessment of risk to users

TOX/2021/23

Draft COT principles for assessing risks from less than lifetime exposure or variable exposure over a lifetime: Second draft statement

TOX/2021/24

Discussion paper for the prioritisation of dietary components and xenobiotics for future papers on their effects on maternal
health – Part 2

TOX/2021/25

Alcohol and the maternal diet: The 2016 Chief Medical Officers report.

TOX/2021/26

The potential effects of ginger and ginger supplements during pregnancy and lactation

TOX/2021/27

Update on the work of other advisory committees - for information

Final minutes of the meeting of the Committee on 4th May 2021

*PDF coming soon*